RESONAT-2 Trial Predictions for Patients With CLL
Upcoming RESONAT-2 trial results for patients with chronic lymphocytic leukemia (CLL).
William G. Weirda, MD, PhD, medical director of the Leukemia Center at The University of Texas MD Anderson Cance...
Author: onclivetv
Added: 03/23/2015
Source: Oncology Tube - Category: Cancer & Oncology Source Type: podcasts
More News: Cancer & Oncology | Chronic Leukemia | Chronic Lymphocytic Leukemia | Leukemia | Texas University